On Monday, I had my second infusion. My pre-lab results showed my platelets at 326,000 and my LDH was normal – numbers I haven't seen since before my ET diagnosis. So far, I'm only experiencing fatigue, which is to be expected as my body adjusts. Depending on how my platelet count responds, my doctor may take me off low-dose aspirin. I'll have updated numbers next week and we'll adjust my treatment plan accordingly. Currently, I'm receiving a 750mg infusion every two weeks, which will continue indefinitely. My platelet count dropped significantly in just two weeks, so I'm interested to see what dosage will be most effective long-term.
My coordinator mentioned that Stanford will likely start phase two of the trial at the end of the year and expand the criteria for qualification. If anyone is interested in this trial, it might be worth considering.
That's all for now. Have a great day!